|This document is available in two formats: this web page (for browsing content) and PDF (comparable to original document formatting). To view the PDF you will need Acrobat Reader, which may be downloaded from the Adobe site. For an official signed copy, please contact the Antitrust Documents Group.|
| UNITED STATES DISTRICT COURT|
FOR THE DISTRICT OF COLUMBIA
PLAINTIFF UNITED STATES MOTION AND MEMORANDUM
Pursuant to Section 2(b) of the Antitrust Procedures and Penalties Act, 15 U.S.C. ï½§ 16(b)-(h) ("APPA"), plaintiff United States of America ("United States") moves for entry of the proposed Final Judgment filed in this civil antitrust proceeding. The Final Judgment may be entered at this time without further hearing if the Court determines that entry is in the public interest. The Competitive Impact Statement, filed in this matter on May 21, 2010, explains why entry of the proposed Final Judgment would be in the public interest. The United States is filing simultaneously with this Motion and Memorandum a Certificate of Compliance setting forth the steps taken by the parties to comply with all applicable provisions of the Antitrust Procedures and Penalties Act, 15 U.S.C. ï½§ 16(b)-(h) ("APPA") and certifying that the statutory waiting period has expired.
On May 21, 2010, the United States and the plaintiff states filed a civil antitrust Complaint alleging that the acquisition of Kerasotes Showplace Theatres, LLC ("Kerasotes"), by AMC Entertainment Holdings, Inc. ("AMC"), would substantially lessen competition, in violation of Section 7 of the Clayton Act, as amended, 15 U.S.C. ï½§ 18. The Complaint alleges that AMC and Kerasotes were two of very few, first-run, commercial theatres or, in some cases, were the only first-run, commercial theatres in parts of Illinois, Colorado, and Indiana ("relevant markets"). As alleged in the Complaint, the transaction would remove a significant competitor in an already highly concentrated and difficult-to-enter first-run, commercial theatre market, which would substantially lessen competition in the relevant markets, thereby harming consumers. Accordingly, the Complaint seeks to prevent the anticompetitive effects of the acquisition by requesting, among other things: (1) a judgment that the acquisition, if consummated, would violate Section 7 of the Clayton Act, and (2) relief that enjoins the parties from consummating the merger.
When the Complaint was filed, a proposed Final Judgment ("Judgment"), which is designed to eliminate the anticompetitive effects of the acquisition, a Competitive Impact Statement, and a Hold Separate Stipulation and Order ("Hold Separate Order") were also filed. Defendant AMC was allowed to consummate its acquisition of Kerasotes, but defendants were required to divest, as viable business operations, certain theatres in the relevant markets ("Theatre Assets"), within 60 days after the filing of the Complaint, or five days after notice of the entry of the Final Judgment by the Court, whichever is later. If the defendants do not complete the divestitures within the prescribed time, then, under the terms of the proposed Final Judgment, this Court will appoint a trustee to sell the Theatre Assets. The Hold Separate and proposed Final Judgment require defendant AMC to preserve, maintain, and continue to operate the Theatre Assets in the ordinary course of business, including exerting reasonable efforts to maintain and increase sales and revenues. The Competitive Impact Statement explains the basis for the Complaint and the reasons why the entry of the proposed Final Judgment would be in the public interest.
Entry of the proposed Final Judgment would terminate this action, except that the Court would retain jurisdiction to construe, modify, or enforce the provisions of the proposed Final Judgment and to punish violations thereof.
II. Compliance with the APPA
The APPA requires a sixty-day period for the submission of public comments on the proposed Final Judgment, 15 U.S.C. ï½§ 16(b). In this case, the comment period terminated on August 2, 2010, and the United States received no public comments. The United States has filed a Certificate of Compliance simultaneously with this Motion and Memorandum that states all the requirements of the APPA have been satisfied. It is now appropriate for the Court to make the public interest determination required by 15 U.S.C. ï½§ 16(e) and to enter the Final Judgment.
III. Standard of Judicial Review
Before entering the proposed Final Judgment, the Court is to determine whether the Judgment "is in the public interest." 15 U.S.C. ï½§ 16(e). In making that determination, the Court may consider:
15 U.S.C. ï½§ 16(e).
In its Competitive Impact Statement previously filed with the Court on May 21, 2010, the United States explained the meaning and proper application of the public interest standard under the APPA and now incorporates those statements herein by reference. The public, including affected competitors and customers, has had the opportunity to comment on the proposed Final Judgment as required by law. There has been no showing that the proposed settlement constitutes an abuse of the United States' discretion or that it is not within the zone of settlements consistent with the public interest.
For the reasons set forth in this Motion and Memorandum and in the Competitive Impact Statement, the Court should find that the proposed Final Judgment is in the public interest and should enter the proposed Final Judgment without further hearings. The United States respectfully requests that the proposed Final Judgment be entered as soon as possible.
Dated: August 5, 2010
CERTIFICATE OF SERVICE
I, Gregg I. Malawer, hereby certify that on August 5, 2010, I caused copies of the foregoing Motion and Memorandum for Entry of Final Judgment to be served electronically to duly authorized legal representatives of those parties, as follows:
By electronic mail:
Counsel of Record for Defendants
Marc E. Raven